Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | PTPRZ1 | P23471 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4708715 | 0.98 | MAPT (0.50) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL3957337 | 0.79 | IDO1 (0.43) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL105639 | 0.78 | MAPT (0.45) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL1258399 | 0.76 | L3MBTL1 (0.54) | IDO1THRBMAPTCYP3A4ALDH1A1 | |
| SCHEMBL16357660 | 0.76 | PTPN1 (0.36) | PTPN1PTPRZ1ALDH1A1CA2HTT | |
| SCHEMBL11624285 | 0.76 | ADH1B (0.41) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL11624279 | 0.76 | MEN1 (0.40) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL3166445 | 0.76 | TAAR1 (0.47) | IDO1MAOA | |
| SCHEMBL31230181 | 0.75 | IDO1 (0.48) | IDO1MEN1KMT2ATHRBTDP1 | |
| SCHEMBL9482260 | 0.75 | IDO1 (0.61) | IDO1MEN1KMT2ATHRBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 525 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094389-A | Perovskite material, perovskite layer, preparation method of perovskite layer, perovskite solar cell and photovoltaic module | — | 2026-05-26 | — | — | CN | claimed |
| CN-114420852-B | Preparation method of pure-phase RP perovskite film | 河北工业大学 | 2025-05-27 | — | — | CN | claimed |
| CN-114824092-B | Solar cell based on quasi-two-dimensional perovskite and preparation method thereof | 北京炎和科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| CN-116217486-B | Fluorescent compound and preparation method and application thereof | 厦门大学 | 2024-05-14 | — | — | CN | claimed |
| CN-117866616-A | Synthesis method of crown ether nested pyrenyl molecule | 东南大学 | 2024-04-12 | — | — | CN | claimed |
| CN-116903544-A | Preparation method of olanzapine and intermediate thereof | 江苏丽源医药有限公司 | 2023-10-20 | — | — | CN | claimed |
| CN-116574058-A | Lipid-droplet fluorescent probe and preparation method and application thereof | 厦门大学 | 2023-08-11 | — | — | CN | claimed |
| CN-116367565-A | Quasi two-dimensional perovskite nanocrystalline modified three-dimensional perovskite solar cell | 河北工业大学 | 2023-06-30 | — | — | CN | claimed |
| CN-111704575-B | Synthesis method of quinoline-2-thiocarboxamide compound under conditions of no catalyst and no additive | 衡阳师范学院 | 2023-06-09 | — | — | CN | claimed |
| CN-116217486-A | Fluorescent compound and preparation method and application thereof | 厦门大学 | 2023-06-06 | — | — | CN | claimed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | claimed |
| WO-2005037797-A1 | SUBSTITUTED PYRAZOLE UREA COMPOUNDS FOR THE TREATMENT OF INFLAMMATION | PHARMACIA CORPORATION (US) | 2005-04-28 | — | — | WO | claimed |
| US-6376712-B2 | REDUCTION OF THE CORRESPONDING OXIME COMPOUND | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-04-23 | — | — | US | claimed |
| US-6362372-B2 | HYDROGENATION OF A TRIFLUOROBENZYLNITRILE BY HYDROGEN IN AN ORGANIC SOLVENT IN THE PRESENCE OF AMMONIA AND A CATALYST COMPRISING A PLATINUM GROUP ELEMENT; EXTREMELY HIGH YIELDS | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-03-26 | — | — | US | claimed |
| US-20020013500-A1 | Process for producing trifluoromethylbenzylamines | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-01-31 | — | — | US | claimed |
| US-20020007086-A1 | Process for producing trifluoromethylbenzylamines | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-01-17 | — | — | US | claimed |
| US-6331649-B1 | REDUCING AN OXIME BY CATALYTIC HYDROGENTATION IN SOLVENT CONTAINING AN ACID | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-12-18 | — | — | US | claimed |
| CN-1317006-A | Antiparasitic artemisinin derivatives (endoperoxides) | BAYER AG (DE) | 2001-10-10 | — | — | CN | claimed |
| US-6175041-B1 | HYDROGENATING A TRIFLUOROMETHYLBENZONITRILE WITH HYDROGEN IN AN ORGANIC SOLVENT IN THE PRESENCE OF AMMONIA, USING A RANEY CATALYST | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-01-16 | — | — | US | claimed |
| CN-1181069-A | 5 -(4 -subst. -piperidinyl -1) -3 -aryl -pentanoic acid derivatives as tachykinin receptor antagonist | ZENECA LTD (GB) | 1998-05-06 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007086-A1 | Process for producing trifluoromethylbenzylamines | IDH1, INMT, TH | IDO1 88/4885MEN1 1477/4885KMT2A 802/4885 |
| US-20020013500-A1 | Process for producing trifluoromethylbenzylamines | MAOB, CYP2F1, AGL | IDO1 49/4885MEN1 2111/4885KMT2A 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.